![]() |
市場調査レポート
商品コード
1439351
副鼻腔拡張装置の世界市場:洞察、競合情勢、市場予測:2030年Sinus Dilation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
副鼻腔拡張装置の世界市場:洞察、競合情勢、市場予測:2030年 |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の副鼻腔拡張装置の市場規模は、2023年に15億2,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に9.10%のCAGRで拡大し、2030年には25億5,000万米ドルに達すると予測されています。副鼻腔拡張装置の需要増加は、主に世界人口の間で急性・慢性両方の鼻副鼻腔炎の負担が増加していることに起因しています。さらに、低侵襲治療への嗜好の高まりや、従来の治療法に対するバルーン副鼻腔形成術のメリットも、副鼻腔拡張装置市場の急増につながると予想されます。また、技術進歩の増加や、副鼻腔炎の治療に関連するいくつかの償還政策やイニシアチブの存在などが、副鼻腔拡張装置の世界市場成長の要因となっています。
副鼻腔拡張装置の世界市場を拡大させる主な要因は、世界人口の間で鼻副鼻腔炎の有病率が増加していることです。鼻副鼻腔炎は、鼻腔と副鼻腔の炎症に関連する一般的な疾患です。世界アレルギー機構(World Allergy Organization)の2022年報告によると、慢性鼻副鼻腔炎(CRS)の世界の有病率は、中国で約8%、韓国で8.4%、欧州で11%、米国で12%となっています。また、国際鼻科学会(International Rhinologic Society 2020)の報告によると、通常ウイルス性感冒の結果として起こる急性鼻副鼻腔炎の1年間の有病率は6~15%であるのに対し、CRSは一般人口の5~12%と推定されています。
さらに、COVID-19の突然の発生により、外科手術が滞り、日常的な患者の治療が中断されました。また、多くの医療機関がウイルスの感染を抑制するために定期的な臨床診察を中止しました。さらに、一部の医療機関は致命的なウイルス感染の管理に重点を移したため、鼻科、特に慢性鼻副鼻腔炎に関する手術が遅れ、副鼻腔拡張装置市場に影響を与えた可能性があります。しかし、ワクチンが利用できるようになったことで、副鼻腔に関連する手術を考慮した選択的手術の数は正常化し、パンデミック後の市場の成長を促進すると予想されています。
当レポートでは、世界の副鼻腔拡張装置市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Sinus Dilation Devices Market By Product Type (Balloon Sinuplasty Devices, Sinus Implants/Stents, Functional Endoscopic Sinus Surgery Instruments Set, Others), By End-User (Hospitals, Ent Clinics, And Others), by geography, is expected to expand at a static CAGR forecast till 2030 due to the growing prevalence of chronic rhinosinusitis across the globe and increasing preferences for minimally invasive surgeries such as balloon sinuplasty among the population.
The global sinus dilation devices market was valued at USD 1.52 billion in 2023, growing at a CAGR of 9.10% during the forecast period from 2024 to 2030, to reach USD 2.55 billion by 2030. The rise in demand for sinus dilation devices is primarily attributed to the growing burden of rhinosinusitis both acute and chronic among the worldwide population. Moreover, the rising preference for the minimally invasive procedures and benefit of balloon sinuplasty over conventional treatment methods is also expected to surge the market for sinus dilation devices. Also, increasing technological advancement and the presence of several reimbursement policies and initiatives concerned with the treatment of sinusitis, among others are the factors responsible for global sinus dilation devices market growth.
Sinus Dilation Devices Market Dynamics:
The factor which plays a major role in increasing the global sinus dilation devices market is the increasing prevalence of rhinosinusitis among the worldwide population. Rhinosinusitis is a common condition associated with the inflammation of the nasal cavity along with paranasal sinuses. According to the World Allergy Organization 2022 report, the worldwide prevalence of chronic rhinosinusitis (CRS) ranges from about 8% in China, 8.4% in Korea, 11% in Europe, and 12% in the United States. Also, according to the reports of the International Rhinologic Society 2020, the one-year prevalence of acute rhinosinusitis which is usually the consequence of viral common cold is 6-15% whereas CRS affects an estimated 5-12% of the general population.
Moreover, recent product approvals for technologically advanced sinus dilation devices are also another factor that will contribute to the market growth during the forecasted period. For instance, on May 20, 2022, Intersect ENT, a global ear, nose, and throat ("ENT") medical technology company received CE mark for its PROPEL® Contour (mometasone furoate) sinus implant (specifically designed for inflammation reduction by providing mechanical support and steroid delivery).
Additionally, the sudden outbreak of COVID-19 led to a backlog of surgical procedures and interruption in routine patient care followed by suspension of routine surgeries during the crisis. Also, many health organizations have canceled routine clinical visits to curb the transmission of the virus. Moreover, few health organizations have shifted their focus towards managing the deadly virus infection which led to delayed surgery in rhinology, particularly with regards to chronic rhinosinusitis which might have affected the sinus dilation devices market. However, the availability of vaccines is anticipated to normalize the number of elective surgeries performed considering the procedures related to sinus thereby fuelling the market growth during the post-pandemic.
Hence, the above-mentioned factors are likely to spur the global sinus dilation devices market.
The availability of alternative treatment regimens and lack of skilled otolaryngologists and ENT surgeons are some of the factors likely to impede the sinus dilation devices market.
Sinus Dilation Devices Market Segment Analysis:
Sinus Dilation Devices Market By Product Type (Balloon Sinuplasty Devices, Sinus Implants/Stents, Functional Endoscopic Sinus Surgery Instruments Set, Others), By End-User (Hospitals, ENT Clinics, And Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Sinus Dilation Devices product segment, the balloon sinuplasty devices are projected to hold the largest market share during the forecasted period. This is due to the advantages exhibit by the balloon sinuplasty over traditional sinus surgery. Balloon sinuplasty uses a small, flexible, balloon catheter to open the blocked passageway and facilitate drainage of mucus. Moreover, this surgery is cost-effective and has faster recovery. Also, it requires no cutting nor removal of bone and tissue. Thus, has high demand among the patient population which ultimately leads to the segmental growth of the sinus dilation devices.
Moreover, the presence of the latest commercial medical policy for balloon sinus ostial dilation is further anticipated to augment the market for sinus dilation devices. For instance, United Healthcare policy number 2022T0571K for balloon sinus dilation is effective from August 01, 2022.
Hence, all the aforementioned factors will lead to the segmental growth of the sinus dilation devices market in the coming years.
North America is expected to dominate the Overall Sinus Dilation Devices Market:
Among all the regions, North America is expected to occupy a major share in the overall sinus dilation devices market during the forthcoming years. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of a well-established reimbursement policy and recent product approvals in the region is projected to augment the sinus dilation devices regional market.
For instance, as per the 2022 data of the Centre for Disease Control and Prevention, in the US, there are approximately 28.9 million adult persons diagnosed with sinusitis.
In addition, the rising number of sinus surgeries and preference for minimally invasive surgeries among the patient population in the region are also anticipated to propel the sinus dilation devices market. For instance, according to the Blue Cross Blue Shield Medical Policies 2020, approximately, 350,000 Functional Endoscopic Sinus Surgery (FESS) procedures are done each year in the US for CRS.
In addition, recent product approvals by the US regulator body the Food and Drug Administration (FDA) and product launches will also contribute to the sinus dilation devices market in the region. In 2019, Dalent Medical, Miami-based ear, nose, and throat Device Company commercially released its Sinusleeve, a single-use, disposable balloon sinus dilation device (BSD) used for treating chronic sinusitis.
Moreover, the presence of key market players active in sinus dilation devices manufacturers such as Johnson & Johnson, Stryker, Dalent Medical, Intersect ENT, Inc., among others is also expected to augment the sinus dilation devices market in the region.
Furthermore, the Asia-pacific region has future potential for the sinus dilation devices market. The rising burden of chronic rhinosinusitis in the region. For instance, as per the National Health Portal of India 2019 data, 134 million Indians were suffering from chronic sinusitis. Moreover, improving the healthcare system, rise in disposable income, rapid urbanization, and government initiative to increase access to safe and affordable surgery, especially in low and middle-income countries will boost the sinus dilation devices market in the region.
Sinus Dilation Devices Market Key Players:
Some of the key market players operating in the Sinus Dilation Devices market include Johnson & Johnson, Stryker, Dalent Medical, Intersect ENT, Inc., Smith & Nephew, Medtronic, Meril Life Sciences Pvt. Ltd., Olympus, Jilin Coronado Medical Apparatus Co., Ltd., Leno Medical Technology (Shanghai) Co., Ltd., SPIGGLE & THEIS Medizintechnik GmbH, InnAccel, Surgical Holdings., SinuPulse, Sklar Surgical Instruments, XION, Entermed, Optim LLC, KARL STORZ, Wolf GmbH, and others.
Recent Developmental Activities in the Sinus Dilation Devices Market:
In July 2022, Intersect ENT, Inc. commercially launched its VenSure balloon sinus dilation system in the U.S.
In September 2020, Intersect ENT, Inc. entered into an agreement to acquire Fiagon AG Medical Technologies. The combination of both the company's portfolio allows to deliver more comprehensive surgical solutions across the sinusitis care continuum
In August 2020, Acclarent Inc. received FDA clearance for its Next Generation Balloon Dilation System, an integrated balloon sinuplasty (BSP) and Eustachian tube (ET) dilation device intended to provide a means to access the sinus space within and across nasal and sinus structures.
Key Takeaways from the Sinus Dilation Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyse suitable indicators, our experts are closely watching the Sinus Dilation Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Sinus Dilation Devices Market.
Various opportunities available for the other competitor in the Sinus Dilation Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Sinus Dilation Devices market growth in the coming future?
Target Audience who can be benefited from the Sinus Dilation Devices Market Report Study
Sinus Dilation Devices providers
Research organizations and consulting companies
Sinus Dilation Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Sinus Dilation Devices
Various End-users who want to know more about the Sinus Dilation Devices Market and latest technological developments in the Sinus Dilation Devices market.
Frequently Asked Questions for the Sinus Dilation Devices Market:
Sinus dilation devices widen the opening of the sinuses during sinus surgery to treat sinus drainage problems. Sinus dilation devices comprise endoscopes (sinuscope and rhinoscope) for visualization during surgery along with a sinus balloon dilation system, sinus implants, and others.
The global sinus dilation devices market was valued at USD 1.52 billion in 2023, growing at a CAGR of 9.10% during the forecast period from 2024 to 2030, to reach USD 2.55 billion by 2030.
The major factors driving the demand for Sinus Dilation Devices are the rising burden of sinusitis across the globe. Recent product approvals, product launches, and the presence of several reimbursement policies and initiatives concerned with the treatment of sinusitis are also the factors responsible for the sinus dilation devices market growth.
Some of the key market players operating in the Sinus Dilation Devices market include Johnson & Johnson, Stryker, Dalent Medical, Intersect ENT, Inc., Smith & Nephew, Medtronic, Meril Life Sciences Pvt. Ltd., Olympus, Jilin Coronado Medical Apparatus Co., Ltd., Leno Medical Technology (Shanghai) Co., Ltd., SPIGGLE & THEIS Medizintechnik GmbH, InnAccel, Surgical Holdings., SinuPulse, Sklar Surgical Instruments, XION, Entermed, Optim LLC, KARL STORZ, Wolf GmbH, and others.
Among all the regions, North America is expected to occupy a major share in the overall sinus dilation devices market during the forthcoming years 2024-2030. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of a well-established reimbursement policy and recent product approvals in the region is projected to augment the sinus dilation devices regional market.